3,4,7,8-tetramethyl-1,10-phenanthroline profile

ID Source	ID
PubMed CID	74265
CHEMBL ID	99384
SCHEMBL ID	136654
MeSH ID	M0088847

Synonym
BIDD:GT0406
AC-1871
CHEMBL99384 ,
3,4,7,8-tetramethyl-[1,10]phenanthroline
3,4,7,8-tetramethyl-1,10-phenanthroline
3,4,7,8-me4phenan
1660-93-1
3,4,7,8-tetramethyl-1,10-phenanthroline, >=98%
T0847
AKOS007930862
3,4,7,8-tetramethyl-1,10-diazaphenanthrene
tm-1,10-p
1,10-phenanthroline, 3,4,7,8-tetramethyl-
einecs 216-762-4
3,4,7,8-tetramethylphenanthroline
bdbm50401347
FT-0614180
AM84569
SCHEMBL136654
DTXSID2061856
3,4,7,8-tetramethyl-1,10-phenantroline
3,4,7,8-tetramethyl-1,10-phenanthrolin
3, 4,7,8-tetramethyl-1,10-phenanthrolin
3,4,7,8-tetramethylphenantroline
W-107928
mfcd00004974
CS-D1715
AC1714
3`4`7`8-tetramethyl-1`10-phenanthroline
BBL102541
SY004672
STL556344
3,4,7,8-tetramethyl-1,10-diazaphenanthrene; 3,4,7,8-tetramethyl-o-phenanthroline; 3,4,7,8-tetramethylphenanthroline
AS-15524
BCP11189
EN300-266681
Z2768172030
HY-34515

Protein	Taxonomy	Measurement	Average	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
C-C chemokine receptor type 1	Homo sapiens (human)	IC50 (µMol)	164.7445	0.0007	0.2002	2.5000	AID716289
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Protein	Taxonomy	Measurement	Average	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
C-C chemokine receptor type 1	Homo sapiens (human)	EC50 (µMol)	1.5424	1.5000	2.9856	6.3096	AID716296
C-C chemokine receptor type 5	Homo sapiens (human)	EC50 (µMol)	1.0000	0.0070	2.0936	5.0119	AID716295
C-C chemokine receptor type 8	Homo sapiens (human)	EC50 (µMol)	0.4906	0.4800	3.7229	7.9433	AID716294
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Process	via Protein(s)	Taxonomy
dendritic cell chemotaxis	C-C chemokine receptor type 1	Homo sapiens (human)
monocyte chemotaxis	C-C chemokine receptor type 1	Homo sapiens (human)
calcium ion transport	C-C chemokine receptor type 1	Homo sapiens (human)
intracellular calcium ion homeostasis	C-C chemokine receptor type 1	Homo sapiens (human)
exocytosis	C-C chemokine receptor type 1	Homo sapiens (human)
chemotaxis	C-C chemokine receptor type 1	Homo sapiens (human)
immune response	C-C chemokine receptor type 1	Homo sapiens (human)
cell adhesion	C-C chemokine receptor type 1	Homo sapiens (human)
cell surface receptor signaling pathway	C-C chemokine receptor type 1	Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger	C-C chemokine receptor type 1	Homo sapiens (human)
positive regulation of cytosolic calcium ion concentration	C-C chemokine receptor type 1	Homo sapiens (human)
cell-cell signaling	C-C chemokine receptor type 1	Homo sapiens (human)
response to wounding	C-C chemokine receptor type 1	Homo sapiens (human)
negative regulation of gene expression	C-C chemokine receptor type 1	Homo sapiens (human)
cytokine-mediated signaling pathway	C-C chemokine receptor type 1	Homo sapiens (human)
positive regulation of cell migration	C-C chemokine receptor type 1	Homo sapiens (human)
negative regulation of bone mineralization	C-C chemokine receptor type 1	Homo sapiens (human)
positive regulation of osteoclast differentiation	C-C chemokine receptor type 1	Homo sapiens (human)
positive regulation of calcium ion transport	C-C chemokine receptor type 1	Homo sapiens (human)
chemokine-mediated signaling pathway	C-C chemokine receptor type 1	Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascade	C-C chemokine receptor type 1	Homo sapiens (human)
positive regulation of monocyte chemotaxis	C-C chemokine receptor type 1	Homo sapiens (human)
calcium-mediated signaling	C-C chemokine receptor type 1	Homo sapiens (human)
cell chemotaxis	C-C chemokine receptor type 1	Homo sapiens (human)
inflammatory response	C-C chemokine receptor type 1	Homo sapiens (human)
MAPK cascade	C-C chemokine receptor type 5	Homo sapiens (human)
dendritic cell chemotaxis	C-C chemokine receptor type 5	Homo sapiens (human)
calcium ion transport	C-C chemokine receptor type 5	Homo sapiens (human)
chemotaxis	C-C chemokine receptor type 5	Homo sapiens (human)
cellular defense response	C-C chemokine receptor type 5	Homo sapiens (human)
cell surface receptor signaling pathway	C-C chemokine receptor type 5	Homo sapiens (human)
G protein-coupled receptor signaling pathway	C-C chemokine receptor type 5	Homo sapiens (human)
cell-cell signaling	C-C chemokine receptor type 5	Homo sapiens (human)
release of sequestered calcium ion into cytosol by sarcoplasmic reticulum	C-C chemokine receptor type 5	Homo sapiens (human)
calcium-mediated signaling	C-C chemokine receptor type 5	Homo sapiens (human)
signaling	C-C chemokine receptor type 5	Homo sapiens (human)
symbiont entry into host cell	C-C chemokine receptor type 5	Homo sapiens (human)
chemokine-mediated signaling pathway	C-C chemokine receptor type 5	Homo sapiens (human)
response to cholesterol	C-C chemokine receptor type 5	Homo sapiens (human)
cellular response to lipopolysaccharide	C-C chemokine receptor type 5	Homo sapiens (human)
negative regulation of macrophage apoptotic process	C-C chemokine receptor type 5	Homo sapiens (human)
inflammatory response	C-C chemokine receptor type 5	Homo sapiens (human)
positive regulation of cytosolic calcium ion concentration	C-C chemokine receptor type 5	Homo sapiens (human)
immune response	C-C chemokine receptor type 5	Homo sapiens (human)
cell chemotaxis	C-C chemokine receptor type 5	Homo sapiens (human)
chemotaxis	C-C chemokine receptor type 8	Homo sapiens (human)
cell adhesion	C-C chemokine receptor type 8	Homo sapiens (human)
G protein-coupled receptor signaling pathway	C-C chemokine receptor type 8	Homo sapiens (human)
chemokine-mediated signaling pathway	C-C chemokine receptor type 8	Homo sapiens (human)
positive regulation of cytosolic calcium ion concentration	C-C chemokine receptor type 8	Homo sapiens (human)
immune response	C-C chemokine receptor type 8	Homo sapiens (human)
cell chemotaxis	C-C chemokine receptor type 8	Homo sapiens (human)
calcium-mediated signaling	C-C chemokine receptor type 8	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Process	via Protein(s)	Taxonomy
phosphatidylinositol phospholipase C activity	C-C chemokine receptor type 1	Homo sapiens (human)
chemokine receptor activity	C-C chemokine receptor type 1	Homo sapiens (human)
protein binding	C-C chemokine receptor type 1	Homo sapiens (human)
C-C chemokine receptor activity	C-C chemokine receptor type 1	Homo sapiens (human)
C-C chemokine binding	C-C chemokine receptor type 1	Homo sapiens (human)
chemokine (C-C motif) ligand 7 binding	C-C chemokine receptor type 1	Homo sapiens (human)
chemokine (C-C motif) ligand 5 binding	C-C chemokine receptor type 1	Homo sapiens (human)
virus receptor activity	C-C chemokine receptor type 5	Homo sapiens (human)
actin binding	C-C chemokine receptor type 5	Homo sapiens (human)
phosphatidylinositol phospholipase C activity	C-C chemokine receptor type 5	Homo sapiens (human)
chemokine receptor activity	C-C chemokine receptor type 5	Homo sapiens (human)
protein binding	C-C chemokine receptor type 5	Homo sapiens (human)
coreceptor activity	C-C chemokine receptor type 5	Homo sapiens (human)
C-C chemokine receptor activity	C-C chemokine receptor type 5	Homo sapiens (human)
C-C chemokine binding	C-C chemokine receptor type 5	Homo sapiens (human)
identical protein binding	C-C chemokine receptor type 5	Homo sapiens (human)
chemokine (C-C motif) ligand 5 binding	C-C chemokine receptor type 5	Homo sapiens (human)
chemokine receptor activity	C-C chemokine receptor type 8	Homo sapiens (human)
coreceptor activity	C-C chemokine receptor type 8	Homo sapiens (human)
C-C chemokine receptor activity	C-C chemokine receptor type 8	Homo sapiens (human)
C-C chemokine binding	C-C chemokine receptor type 8	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Process	via Protein(s)	Taxonomy
plasma membrane	C-C chemokine receptor type 1	Homo sapiens (human)
external side of plasma membrane	C-C chemokine receptor type 1	Homo sapiens (human)
external side of plasma membrane	C-C chemokine receptor type 1	Homo sapiens (human)
cytoplasm	C-C chemokine receptor type 1	Homo sapiens (human)
cell surface	C-C chemokine receptor type 5	Homo sapiens (human)
endosome	C-C chemokine receptor type 5	Homo sapiens (human)
plasma membrane	C-C chemokine receptor type 5	Homo sapiens (human)
external side of plasma membrane	C-C chemokine receptor type 5	Homo sapiens (human)
cell surface	C-C chemokine receptor type 5	Homo sapiens (human)
external side of plasma membrane	C-C chemokine receptor type 5	Homo sapiens (human)
cytoplasm	C-C chemokine receptor type 5	Homo sapiens (human)
plasma membrane	C-C chemokine receptor type 8	Homo sapiens (human)
external side of plasma membrane	C-C chemokine receptor type 8	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (17)

Assay ID	Title	Year	Journal	Article
AID716291	Ratio of ZnPhe EC50 to compound EC50 for human CCR8 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as IP3 turnover by liquid scintillation counting analysis	2012	Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18	Modulation in selectivity and allosteric properties of small-molecule ligands for CC-chemokine receptors.
AID716298	Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis relative to basal level	2012	Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18	Modulation in selectivity and allosteric properties of small-molecule ligands for CC-chemokine receptors.
AID716294	Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis	2012	Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18	Modulation in selectivity and allosteric properties of small-molecule ligands for CC-chemokine receptors.
AID716289	Displacement of [125I]-CCL3 from human CCR1 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs	2012	Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18	Modulation in selectivity and allosteric properties of small-molecule ligands for CC-chemokine receptors.
AID218537	Inhibition of beta-hematin formation; Not active	2004	Journal of medicinal chemistry, May-20, Volume: 47, Issue:11	In vitro antimalarial activity of a series of cationic 2,2'-bipyridyl- and 1,10-phenanthrolineplatinum(II) benzoylthiourea complexes.
AID158223	In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum D10; Not determined	2004	Journal of medicinal chemistry, May-20, Volume: 47, Issue:11	In vitro antimalarial activity of a series of cationic 2,2'-bipyridyl- and 1,10-phenanthrolineplatinum(II) benzoylthiourea complexes.
AID716295	Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis	2012	Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18	Modulation in selectivity and allosteric properties of small-molecule ligands for CC-chemokine receptors.
AID716297	Allosteric modulation at human CCR1 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis relative to basal level	2012	Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18	Modulation in selectivity and allosteric properties of small-molecule ligands for CC-chemokine receptors.
AID716300	Ratio of ZnPhe EC50 to compound EC50 for human CCR1 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as IP3 turnover by liquid scintillation counting analysis	2012	Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18	Modulation in selectivity and allosteric properties of small-molecule ligands for CC-chemokine receptors.
AID716302	Ratio of ZnPhe EC50 to compound EC50 for human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as IP3 turnover by liquid scintillation counting analysis	2012	Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18	Modulation in selectivity and allosteric properties of small-molecule ligands for CC-chemokine receptors.
AID716290	Allosteric modulation at human CCR8 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis relative to basal level	2012	Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18	Modulation in selectivity and allosteric properties of small-molecule ligands for CC-chemokine receptors.
AID716296	Allosteric modulation at human CCR1 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as {3H]IP3 turnover by liquid scintillation counting analysis	2012	Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18	Modulation in selectivity and allosteric properties of small-molecule ligands for CC-chemokine receptors.
AID716287	Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs	2012	Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18	Modulation in selectivity and allosteric properties of small-molecule ligands for CC-chemokine receptors.
AID158225	In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum K1; Not determined	2004	Journal of medicinal chemistry, May-20, Volume: 47, Issue:11	In vitro antimalarial activity of a series of cationic 2,2'-bipyridyl- and 1,10-phenanthrolineplatinum(II) benzoylthiourea complexes.
AID72977	Ability to associate with ferriprotoporphyrin IX	2004	Journal of medicinal chemistry, May-20, Volume: 47, Issue:11	In vitro antimalarial activity of a series of cationic 2,2'-bipyridyl- and 1,10-phenanthrolineplatinum(II) benzoylthiourea complexes.
AID716288	Displacement of [125I]-CCL3 from human CCR1 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs relative to basal level	2012	Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18	Modulation in selectivity and allosteric properties of small-molecule ligands for CC-chemokine receptors.
AID716293	Binding affinity to Zn(II) after 2 hrs using FluoZin-3 by fuorescence assay	2012	Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18	Modulation in selectivity and allosteric properties of small-molecule ligands for CC-chemokine receptors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	2 (25.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (25.00)	29.6817
2010's	4 (50.00)	24.3611
2020's	0 (0.00)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	8 (100.00%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Classes	Roles
benzaldehyde [no description available]	2.06	1	benzaldehydes	EC 3.1.1.3 (triacylglycerol lipase) inhibitor; EC 3.5.5.1 (nitrilase) inhibitor; flavouring agent; fragrance; odorant receptor agonist; plant metabolite
nickel Nickel: A trace element with the atomic symbol Ni, atomic number 28, and atomic weight 58.69. It is a cofactor of the enzyme UREASE.. nickel ion : A nickel atom having a net electric charge.. nickel atom : Chemical element (nickel group element atom) with atomic number 28.	1.95	1	metal allergen; nickel group element atom	epitope; micronutrient
1,10-phenanthroline 1,10-phenanthroline: RN given refers to parent cpd; inhibits Zn-dependent metalloproteinases	2.77	3	phenanthroline	EC 2.7.1.1 (hexokinase) inhibitor; EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor
2,2'-dipyridyl 2,2'-Dipyridyl: A reagent used for the determination of iron.. 2,2'-bipyridine : A bipyridine in which the two pyridine moieties are linked by a bond between positions C-2 and C-2'.	2.74	3	bipyridine	chelator; ferroptosis inhibitor
chloroquine Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.. chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.	2.02	1	aminoquinoline; organochlorine compound; secondary amino compound; tertiary amino compound	anticoronaviral agent; antimalarial; antirheumatic drug; autophagy inhibitor; dermatologic drug
flucytosine Flucytosine: A fluorinated cytosine analog that is used as an antifungal agent.. flucytosine : An organofluorine compound that is cytosine that is substituted at position 5 by a fluorine. A prodrug for the antifungal 5-fluorouracil, it is used for the treatment of systemic fungal infections.	2.13	1	aminopyrimidine; nucleoside analogue; organofluorine compound; pyrimidine antifungal drug; pyrimidone	prodrug
ethidium Ethidium: A trypanocidal agent and possible antiviral agent that is widely used in experimental cell biology and biochemistry. Ethidium has several experimentally useful properties including binding to nucleic acids, noncompetitive inhibition of nicotinic acetylcholine receptors, and fluorescence among others. It is most commonly used as the bromide.. ethidium : The fluorescent compound widely used in experimental cell biology and biochemistry to reveal double-stranded DNA and RNA.	2.13	1	phenanthridines	fluorochrome; intercalator
1,2-cyclohexanediamine 1,2-cyclohexanediamine: RN given refers to cpd without isomeric designation	2.13	1	primary aliphatic amine
reserpine Reserpine: An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. Reserpine inhibits the uptake of norepinephrine into storage vesicles resulting in depletion of catecholamines and serotonin from central and peripheral axon terminals. It has been used as an antihypertensive and an antipsychotic as well as a research tool, but its adverse effects limit its clinical use.. reserpine : An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria.	1.95	1	alkaloid ester; methyl ester; yohimban alkaloid	adrenergic uptake inhibitor; antihypertensive agent; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; environmental contaminant; first generation antipsychotic; plant metabolite; xenobiotic
ampicillin Ampicillin: Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic.. ampicillin : A penicillin in which the substituent at position 6 of the penam ring is a 2-amino-2-phenylacetamido group.	2.13	1	beta-lactam antibiotic; penicillin allergen; penicillin	antibacterial drug
cyclopentane Cyclopentanes: A group of alicyclic hydrocarbons with the general formula R-C5H9.. cyclopentanes : Cyclopentane and its derivatives formed by substitution.	2.08	1	cycloalkane; cyclopentanes; volatile organic compound	non-polar solvent
4,4'-dimethyl-2,2'-bipyridine 4,4'-dimethyl-2,2'-bipyridine: structure in first source	2.44	2
5,5'-dimethyl-2,2'-bipyridyl 5,5'-dimethyl-2,2'-bipyridyl: structure in first source	2.07	1	bipyridines
iridium Iridium: A metallic element with the atomic symbol Ir, atomic number 77, and atomic weight 192.22.	2.06	1	cobalt group element atom; platinum group metal atom
platinum Platinum: A heavy, soft, whitish metal, resembling tin, with atomic number 78, atomic weight 195.084, symbol Pt. It is used in manufacturing equipment for laboratory and industrial use. It occurs as a black powder (platinum black) and as a spongy substance (spongy platinum) and may have been known in Pliny's time as alutiae.	2.08	1	elemental platinum; nickel group element atom; platinum group metal atom
ruthenium Ruthenium: A hard, brittle, grayish-white rare earth metal with an atomic symbol Ru, atomic number 44, and atomic weight 101.07. It is used as a catalyst and hardener for PLATINUM and PALLADIUM.	1.94	1	iron group element atom; platinum group metal atom
neocuproine neocuproine: Spectrophotometric determination of copper and ultramicro blood sugar determinations; structure; RN given refers to parent cpd. neocuproine : A member of the class of phenanthrolines that is 1,10-phenanthroline bearing two methyl substituents at positions 2 and 9.	2.07	1	phenanthrolines	chelator; copper chelator
1,7-phenanthroline [no description available]	3.25	6	phenanthroline
2,2',2''-terpyridine 2,2',2''-terpyridine: RN given refers to parent cpd. 2,2':6',2''-terpyridine : A tridentate heterocyclic ligand that binds metals at three meridional sites giving two adjacent 5-membered MN2C2 chelate rings.	2.07	1	terpyridines	chelator
5-nitro-1,10-phenanthroline 5-nitro-1,10-phenanthroline: structure in first source	2.02	1
5-methyl-1,10-phenanthroline [no description available]	2.74	3
ferric ferrocyanide ferric ferrocyanide: antidote to thallium poisoning; RN given refers to Fe(+3)[3:4] salt; structure	2.05	1
emetine dihydrochloride emetine dihydrochloride : The dihydrochloride salt of emetine.. emetine dihydrochloride hydrate : A hydrate that is the monohydrate of the dihydrochloride salt of emetine.	2.02	1	hydrochloride	anticoronaviral agent; antimalarial; antineoplastic agent; antiprotozoal drug; antiviral agent; autophagy inhibitor; emetic; protein synthesis inhibitor

Condition	Relationship Strength	Studies
Benign Neoplasms [description not available]	1.94	1
Experimental Neoplasms [description not available]	1.94	1
Ascites Accumulation or retention of free fluid within the peritoneal cavity.	6.94	1
Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.	1.94	1

3,4,7,8-tetramethyl-1,10-phenanthroline

Cross-References

Synonyms (38)

Protein Targets (3)

Inhibition Measurements

Activation Measurements

Biological Processes (34)

Molecular Functions (11)

Ceullar Components (5)

Bioassays (17)

Research

Studies (8)

Market Indicators

Research Demand Index: 27.07

Study Types

3,4,7,8-tetramethyl-1,10-phenanthroline

Cross-References

Synonyms (38)

Protein Targets (3)

Inhibition Measurements

Activation Measurements

Biological Processes (34)

Molecular Functions (11)

Ceullar Components (5)

Bioassays (17)

Research

Studies (8)

Market Indicators

Research Demand Index: 27.07

Study Types

Related Drugs (23)

Related Conditions (4)